MDWD MediWound Ltd.
MediWound Ltd. (MDWD) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $0.63 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.4% since its last earnings release on November 12, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About MediWound Ltd.
MediWound Ltd. is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Held By 1 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.